M-tron Industries, Inc.·4/A

Apr 7, 4:36 PM ET

Drafts William Arnold 4/A

4/A · M-tron Industries, Inc. · Filed Apr 7, 2026

Research Summary

AI-generated summary of this filing

Updated

M-tron (MPTI) President William Drafts Exercises Derivatives

What Happened

  • William Drafts, President of M-tron Industries (MPTI), exercised in‑the‑money derivatives on Dec 19 and Dec 23, 2025, acquiring a total of 4,446 shares. Of those, 741 shares were acquired at $47.50 each for a cash outlay of $35,198 (reported as $9,548 on 12/19 for 201 shares and $25,650 on 12/23 for 540 shares). An additional 3,705 shares were recorded as acquired at $0.00 (derivative conversions). He also disposed of 3 shares on 12/19 (reported as $0.00).

Key Details

  • Transaction dates and amounts:
    • 2025-12-19: Acquired 201 shares @ $47.50 ($9,548); acquired 1,005 shares @ $0.00 (derivative); disposed 3 shares @ $0.00.
    • 2025-12-23: Acquired 540 shares @ $47.50 ($25,650); acquired 2,700 shares @ $0.00 (derivative).
  • Total acquired: 4,446 shares (741 paid at $47.50 totaling $35,198; 3,705 at $0.00). Total disposed: 3 shares.
  • Shares owned after transaction: Not disclosed in this filing.
  • Filing status: This is an AMENDED Form 4 filed April 7, 2026, covering transactions dated Dec 19–23, 2025 (the filing is late relative to the transaction dates).
  • Footnotes of note:
    • F1: A granted stock option vests 30% on 4/4/2026, 30% on 4/4/2027, and 40% on 4/4/2028.
    • F2: On April 25, 2025 the company issued warrants (one per share held as of 3/10/25); five warrants permit purchase of one share at $47.50 (subject to adjustment).

Context

  • The filing reports exercises/conversions of derivatives (including warrant exercises consistent with footnote F2) rather than open‑market buys. There is no indication in this Form 4 that the newly acquired shares were immediately sold (i.e., no cashless exercise/sale was reported aside from the small 3‑share disposal).
  • Purchases or exercises by insiders can be informative to investors, but this filing was amended and submitted well after the December transaction dates; also the presence of $0.00 cost entries suggests derivative conversions or non‑cash issuances rather than standard cash purchases.

Insider Transaction Report

Form 4/AAmended
Period: 2025-12-19
Transactions
  • Exercise of In-Money

    Common Stock

    2025-12-19$47.50/sh+201$9,54811,209 total
  • Exercise of In-Money

    Common Stock

    2025-12-23$47.50/sh+540$25,65011,749 total
  • Exercise of In-Money

    Common Stock Warrants (right to purchase)

    [F2]
    2025-12-19+1,0056,303 total
    Exercise: $47.50From: 2025-10-23Exp: 2025-12-23Common Stock (201 underlying)
  • Sale

    Common Stock Warrants (right to purchase)

    [F2]
    2025-12-1936,300 total
    Exercise: $47.50From: 2025-10-23Exp: 2025-12-23Common Stock (0 underlying)
  • Exercise of In-Money

    Common Stock Warrants (right to purchase)

    [F2]
    2025-12-23+2,7003,600 total
    Exercise: $47.50From: 2025-10-23Exp: 2025-12-23Common Stock (540 underlying)
Holdings
  • Stock Option (right to buy)

    [F1]
    Exercise: $40.32From: 2026-04-04Exp: 2030-04-04Common Stock (12,500 underlying)
    12,500
Footnotes (2)
  • [F1]Grant of a stock option of the Issuer vesting as follows: 30% on 4/4/2026, 30% on 4/4/2027, and 40% on 4/4/2028.
  • [F2]On April 25, 2025, holders of the Issuer's Common Stock, par value $0.01 per share (the "Common Stock"), received a dividend of one Common Stock Warrant (the "Warrants") for each share of Common Stock held by such holder as of March 10, 2025. When exercisable, five (5) Warrants will entitle their holder to purchase one share of Common Stock at an exercise price of $47.50 per share, as may be adjusted in accordance with the terms of the Warrants.
Signature
/s/ William A. Drafts|2026-04-07

Documents

1 file
  • 4
    rdgdoc.xml

    FORM 4/A